Request completed
Thank you for confirming your registration.
You can revoke this at any time via the “unsubscribe” link in every e-mail received.
We will verify your request and – should you fulfill the requirements* – will provide you with the information you requested in due time.
Best regards
Your FCF Team
*All information and market analyses published by FCF are exclusively directed to and for the use by current and potential institutional clients, partners and investors. FCF retains the right to reject your request.
NEWS & PRESS
FCF Valuation Monitor – Q4 2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Valuation Monitor – Q4 2023”. The FCF Valuation Monitor is a comprehensive valuation analysis for the German small / midcap market segment
FCF Biotech Venture Capital Monitor – USA 11/2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 11/2023”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
FCF Interest & Corporate Loan Monitor Q3/2023 published
FCF Fox Corporate Finance GmbH is pleased to publish the new “FCF Interest & Corporate Loan Monitor Q3/2023”. FCF regularly conducts comprehensive research regarding the German corporate loan and interest market, based on publically available
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 11/2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 11/2023”. The Monitor is a monthly published overview of venture capital trends in the European
FCF Biotech Venture Capital Monitor – USA 10/2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 10/2023”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As